About
Overview
Company Leadership
Science
Technology Platform
Scientific Publications
Pipeline
Overview
CF101
CF102
CF602
Investor Information
Overview
News / Events
Company Information
Financial Information
Stock Information
SEC Filings
Corporate Governance
Shareholders Meetings
Contact Us
Directions
Investor Information
Overview
News / Events
Press Releases
In The News
Research
Events Calendar
Presentations
Email Alerts
Company Information
Profile
Management
IR Contacts
FAQ
Financial Information
Quarterly & Annual Reports
Stock Information
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Shareholders Meetings
Email Alerts
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2019
2018
2017
2016
2015
2014
2013
2012
Dec 21, 2016 7:00 AM EST
Can-Fite Receives $500,000 Payment as Part of $3 Million Distribution Deal for Liver Cancer Drug Namodenoson (CF102) in South Korea
Dec 16, 2016 7:00 AM EST
New Preclinical Data Show Can-Fite's Namodenoson (CF102) Inhibits Liver Fibrosis -- Supports Potential Efficacy in Treatment of NASH
Nov 25, 2016 7:00 AM EST
Can-Fite Reports Financial Results for Nine Months Ended September 30, 2016 & Provides Clinical Update
Nov 16, 2016 7:00 AM EST
American Medical Association's USAN & World Health Organization's INN Approve "Namodenoson" as Generic Name for Can-Fite's Liver Drug CF102
Nov 9, 2016 7:00 AM EST
Can-Fite Receives Notice of Allowance From U.S. Patent and Trademark Office for Erectile Dysfunction Drug
Nov 7, 2016 7:00 AM EST
Can-Fite to Participate in BIO-Europe Partnering Conference on November 7-9, 2016 in Cologne, Germany
Nov 1, 2016 7:00 AM EDT
Can-Fite Advances Towards a Pivotal Phase III Clinical Trial in Psoriasis with Piclidenoson (CF101) Following Reaching Agreement with EMA
Oct 25, 2016 7:15 AM EDT
Can-Fite Signs Distribution Deal for Liver Cancer Drug CF102 in South Korea
Oct 13, 2016 7:00 AM EDT
Can-Fite Submits Protocol for Phase II Trial of CF102 in the Treatment of NAFLD/NASH
Sep 20, 2016 7:00 AM EDT
Can-Fite Reports New Data on CF102's Liver Protective & Regenerative Properties Published in Scientific Journal
1
2
3
4
Next >>
Show All